Literature DB >> 216130

Cyclic nucleotides in platelet function.

R J Haslam, M M Davidson, J E Fox, J A Lynham.   

Abstract

Inhibition of adenylate cyclase in intact platelets by addition of compounds such as 2', 5' - dideoxyadenosine prevented the inhibition of platelet aggregation by PGE1 but did not affect the responses of platelets to aggregating agents in the absence of PGE1. This confirms that cyclic AMP mediates the effects of PGE1 but indicates that the level of cyclic AMP in unstimulated platelets is too low to affect the actions of aggregating agents. Studies on the phosphorylation of proteins in intact 32P-labelled platelets showed that PGE1 increased the phosphorylation of a membrane-bound polypeptide (P24) and prevented the increased phosphorylation of other polypeptides (P47 and P20) that occurred on addition of inducers of the release reaction. It is suggested that the cyclic AMP-dependent phosphorylation of P24 stimulates the active transport of Ca(2+) out of the platelet cytosol, so preventing phosphorylation of P47 and P20, reactions which may be involved in the release mechanism. As increases in platelet cyclic GMP could be dissociated from both platelet aggregation and the release reaction, it is proposed that the bidirectional regulation of platelet function is achieved primarily by the opposing actions of increases in the concentrations of Ca(2+) and cyclic AMP.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 216130

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  11 in total

1.  P1,P4-dithio-P2,P3-monochloromethylene diadenosine 5',5'''-P1,P4-tetraphosphate: a novel antiplatelet agent.

Authors:  S W Chan; S J Gallo; B K Kim; M J Guo; G M Blackburn; P C Zamecnik
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

2.  12(S)-HETrE, a 12-Lipoxygenase Oxylipin of Dihomo-γ-Linolenic Acid, Inhibits Thrombosis via Gαs Signaling in Platelets.

Authors:  Jennifer Yeung; Benjamin E Tourdot; Reheman Adili; Abigail R Green; Cody J Freedman; Pilar Fernandez-Perez; Johnny Yu; Theodore R Holman; Michael Holinstat
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-07-28       Impact factor: 8.311

3.  Defective platelet aggregation to the calcium ionophore A23187 in a patient with a lifelong bleeding disorder.

Authors:  S J Machin; J P Keenan; B A McVerry
Journal:  J Clin Pathol       Date:  1983-10       Impact factor: 3.411

4.  Triene prostaglandins: prostaglandin D3 and icosapentaenoic acid as potential antithrombotic substances.

Authors:  M O Whitaker; A Wyche; F Fitzpatrick; H Sprecher; P Needleman
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

5.  Shape change of blood platelets brought about by myelin basic protein and other basic polypeptides.

Authors:  A Laubscher; A Pletscher; C G Honegger; J G Richards
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-12       Impact factor: 3.000

6.  Inhibition of prostaglandin E1-responsive platelet adenylate cyclase by heparin: a study of the mechanism of inhibition and its relevance to platelet aggregation.

Authors:  H Amirrasooli; S Mac Neil; S Tomlinson
Journal:  Br J Pharmacol       Date:  1981-07       Impact factor: 8.739

7.  Prostacyclin modulates cholesteryl ester hydrolytic activity by its effect on cyclic adenosine monophosphate in rabbit aortic smooth muscle cells.

Authors:  D P Hajjar; B B Weksler; D J Falcone; J M Hefton; K Tack-Goldman; C R Minick
Journal:  J Clin Invest       Date:  1982-09       Impact factor: 14.808

8.  Thrombin-induced exposure and prostacyclin inhibition of the receptor for factor VIII/von Willebrand factor on human platelets.

Authors:  T Fujimoto; S Ohara; J Hawiger
Journal:  J Clin Invest       Date:  1982-06       Impact factor: 14.808

9.  Shape changes induced by biologically active peptides and nerve growth factor in blood platelets of rabbits.

Authors:  F Gudat; A Laubscher; U Otten; A Pletscher
Journal:  Br J Pharmacol       Date:  1981-11       Impact factor: 8.739

Review 10.  Antiplatelet drugs: clinical pharmacology and therapeutic use.

Authors:  A S Gallus
Journal:  Drugs       Date:  1979-12       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.